GlassScriptPhysician profile
Lynette W Tsai
NPI 1124133988
$6,392.56
in general payments reported to CMS, 2019-2025
23 companies · $650 in 2025
The $650 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,442 · 2020: $898 · 2021: $639 · 2022: $735 · 2023: $908 · 2024: $1,121 · 2025: $650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,604 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,604.20 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $2,291.55 | 2019-2025 | Evenity, Prolia, Prolia |
| Astellas Pharma US INC | $734.13 | 2021-2025 | Veozah, Myrbetriq |
| Radius Health, INC. | $720.45 | 2019-2025 | Tymlos |
| Abbvie INC. | $672.99 | 2019-2025 | Lo Loestrin Fe, Orilissa |
| Bayer Healthcare Pharmaceuticals INC. | $462.54 | 2019-2025 | |
| Covidien LP | $280.16 | 2019 | |
| Pfizer INC. | $155.03 | 2021-2025 | |
| Roche Diagnostics Corporation | $131.67 | 2019-2021 | |
| Exeltis, USA INC. | $129.29 | 2023-2025 | Slynd |
| Avanos Medical | $120.93 | 2019 | |
| Hologic Sales and Service, LLC | $116.69 | 2024-2025 | Myosure Tissue Removal Device, Novasure, Acessa Provu System |
| Merck Sharp & Dohme LLC | $94.99 | 2019-2024 | Gardasil 9, M-M-R II, Gardasil |
| Applied Medical Resources Corporation | $87.33 | 2023 | Gelpoint V-Path |
| Revance Therapeutics, INC. | $74.48 | 2024 | Daxxify |
| Agile Therapeutics, INC. | $61.18 | 2021-2023 | Twirla |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $53.61 | 2021-2022 | |
| Myovant Sciences INC. | $48.97 | 2022 | |
| Coopersurgical, INC. | $44.26 | 2024 | Paragard T 380a, Endosee |
| Intuitive Surgical, INC. | $37.66 | 2019 | |
| Therapeuticsmd, INC. | $23.23 | 2022 | |
| Merz North America, INC. | $19.66 | 2024 | |
| Ethicon US, LLC | $18.34 | 2024 | Ethicon |
| Sumitomo Pharma America, INC. | $13.42 | 2024 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynette Tsai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.